For the quarter ending 2026-03-31, ISCO made $2,315K in revenue. -$220K in net income. Net profit margin of -9.50%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Product sales | 2,315 | 2,155 | 2,369 | 2,447 |
| Cost of sales | 954 | 1,066 | 1,048 | 927 |
| General and administrative | 1,122 | 946 | 789 | 905 |
| Selling and marketing | 273 | 279 | 280 | 286 |
| Research and development | 156 | 177 | 158 | 162 |
| Total operating expenses | 2,505 | 2,468 | 2,275 | 2,280 |
| Loss from operations | -190 | -313 | 94 | 167 |
| Interest expense | 2 | 0 | 1 | 2 |
| Interest expense - related party | 33 | 35 | 36 | 36 |
| Other income | 5 | - | - | - |
| Total other expense, net | -30 | -35 | -37 | -38 |
| Net loss | -220 | -348 | 57 | 129 |
| Undistributed earnings allocated to participating securities | - | - | 28 | 62 |
| Net income (loss) attributable to common stockholders | - | - | 29 | 67 |
| Basic EPS | -0.03 | -0.032 | 0 | 0.01 |
| Diluted EPS | -0.03 | -0.033 | 0 | 0.01 |
| Basic Average Shares | 8,004,389 | 8,004,389 | 8,004,389 | 8,004,389 |
| Diluted Average Shares | 8,004,389 | 7,841,481 | 8,167,297 | 8,004,389 |
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)